Side Effect Registry Immuno-Oncology (SERIO)

Research facility


Location: München, Germany (DE) DE

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article The Side Effect Registry SERIO - Side Effect Registry Immuno-Oncology - documenting, analyzing and better understanding Complex Side Effects under Immunotherapy (2021) Zierold S, Rahimi F, Kramer R, Knauss S, Tomsitz D, French LE, Heinzerling L Conference contribution Serositis in Association with System Therapy with Checkpoint Inhibitors - More frequent than thought? - An Evaluation of the SERIO Adverse Event Registry (2021) Zierold S, Kramer R, Erdmann M, Akcetin SL, Maier AM, Koenig A, Theurich S, et al. Conference contribution